Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Biodesix (BDSX) Accumulated Depreciation & Amortization (2019 - 2025)

Historic Accumulated Depreciation & Amortization for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $11.7 million.

  • Biodesix's Accumulated Depreciation & Amortization rose 4198.08% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 4198.08%. This contributed to the annual value of $9.1 million for FY2024, which is 6275.84% up from last year.
  • Per Biodesix's latest filing, its Accumulated Depreciation & Amortization stood at $11.7 million for Q3 2025, which was up 4198.08% from $10.8 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Accumulated Depreciation & Amortization peaked at $11.7 million during Q3 2025, and registered a low of $5.6 million during Q4 2023.
  • Over the past 5 years, Biodesix's median Accumulated Depreciation & Amortization value was $7.3 million (recorded in 2023), while the average stood at $7.8 million.
  • As far as peak fluctuations go, Biodesix's Accumulated Depreciation & Amortization tumbled by 2003.42% in 2023, and later skyrocketed by 6275.84% in 2024.
  • Biodesix's Accumulated Depreciation & Amortization (Quarter) stood at $6.7 million in 2021, then grew by 3.99% to $7.0 million in 2022, then fell by 20.03% to $5.6 million in 2023, then skyrocketed by 62.76% to $9.1 million in 2024, then increased by 28.22% to $11.7 million in 2025.
  • Its last three reported values are $11.7 million in Q3 2025, $10.8 million for Q2 2025, and $10.1 million during Q1 2025.